相关实验视频
Updated: May 4, 2026

10:58
Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
Published on: July 18, 2016
10.9K
2022年顶级腹膜表面恶性瘤文章,为您的癌症实践提供信息
1Department of Surgery, Division of General Surgery, University of Washington/Fred Hutch Cancer Center, Seattle, WA, USA. hmogal@uw.edu.
Annals of surgical oncology
|May 3, 2024
概括
细胞还原性手术 (CRS) 与高热性腹腔内化学疗法 (HIPEC) 对腹腔表面恶性瘤 (PSMs) 有好处,但晚期病例和长期存活仍然存在挑战,需要进一步研究瘤生物学和新疗法.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 腹膜表面的恶性瘤
背景情况:
- 细胞还原性手术 (CRS) 与高热性腹腔内化疗 (HIPEC) 已发展为管理腹腔表面恶性瘤 (PSMs).
- 虽然CRS改善了瘤结果,但在先进的PSM中仍然存在挑战,HIPEC的作用仍在争论中.
- 经手术后的改善与长期生存率不佳形成鲜明对比,突出显示了未得到满足的需求.
研究的目的:
- 审查最近对PSM患者护理的有影响力的研究.
- 强调需要更好地了解瘤生物学来选择患者.
- 确定对非手术候选人和正在进行全身治疗的候选人的新疗法需求.
主要方法:
- 审查最近发表的有影响力的研究.
- 专注于了解瘤生物学方面的进展.
- 识别新的治疗策略.
主要成果:
- 最近的研究提供了关于管理PSM的见解.
- 更好地了解瘤生物学对于治疗选择至关重要.
- 对于具有挑战性的患者群体,正在出现新的治疗方法.
结论:
- 进一步的研究对于改善PSM的结果至关重要.
- 对瘤生物学有了更深入的了解,将对患者对CRS和HIPEC的选择进行完善.
- 开发新型疗法对于患有晚期疾病或不良外科治疗候选症的患者至关重要.
相关概念视频
Cancer
51.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.7K
Cancer Stem Cells and Tumor Maintenance
4.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer Survival Analysis
863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863

